24807533|t|Ebselen pretreatment attenuates ischemia/reperfusion injury and prevents hyperglycemia by improving hepatic insulin signaling and beta-cell survival in gerbils.
24807533|a|Transient carotid artery occlusion causes ischemia/reperfusion (I/R) injury resulting in neuron and pancreatic beta-cell death with consequential post-stroke hyperglycemia, which can lead to diabetes and may accelerate the development of Alzheimer's disease. Antioxidants have been shown to protect against the I/R injury and destruction of neurons. However, it is unknown whether the protection against I/R injury extends to the pancreatic beta-cells. Therefore, we investigated whether treatment with ebselen, a glutathione peroxidase mimic, prevents neuronal and beta-cell death following I/R in gerbils susceptible to stroke. After 28 days post artery occlusion, there was widespread neuronal cell death in the CA1 of the hippocampus and elevated IL-1beta and TNF-alpha levels. Pretreatment with ebselen prevented the death by 56% and attenuated neurological damage (abnormal eyelid drooping, hair bristling, muscle tone, flexor reflex, posture, and walking patterns). Ischemic gerbils also exhibited impaired glucose tolerance and insulin sensitivity which induced post-stroke hyperglycemia associated with decreased beta-cell mass due to increased beta-cell apoptosis. Ebselen prevented the increased beta-cell apoptosis, possibly by decreasing IL-1beta and TNF-alpha in islets. Ischemia also attenuated hepatic insulin signaling, and expression of GLUT2 and glucokinase, whereas ebselen prevented the attenuation and suppressed gluconeogenesis by decreasing PEPCK expression. In conclusion, antioxidant protection by ebselen attenuated I/R injury of neurons and pancreatic beta-cells and prevented subsequent impairment of glucose regulation that could lead to diabetes and Alzheimer's disease.
24807533	0	7	Ebselen	Chemical	MESH:C042986
24807533	32	59	ischemia/reperfusion injury	Disease	MESH:D015427
24807533	73	86	hyperglycemia	Disease	MESH:D006943
24807533	108	115	insulin	Gene	3630
24807533	152	159	gerbils	Species	10045
24807533	171	195	carotid artery occlusion	Disease	MESH:D002340
24807533	203	223	ischemia/reperfusion	Disease	MESH:D015427
24807533	225	236	I/R) injury	Disease	MESH:D015427
24807533	282	287	death	Disease	MESH:D003643
24807533	307	318	post-stroke	Disease	MESH:D020521
24807533	319	332	hyperglycemia	Disease	MESH:D006943
24807533	352	360	diabetes	Disease	MESH:D003920
24807533	399	418	Alzheimer's disease	Disease	MESH:D000544
24807533	472	482	I/R injury	Disease	MESH:D015427
24807533	565	575	I/R injury	Disease	MESH:D015427
24807533	664	671	ebselen	Chemical	MESH:C042986
24807533	714	732	neuronal and beta-	Disease	MESH:D009410
24807533	737	742	death	Disease	MESH:D003643
24807533	753	756	I/R	Disease	MESH:D015427
24807533	760	767	gerbils	Species	10045
24807533	783	789	stroke	Disease	MESH:D020521
24807533	810	826	artery occlusion	Disease	MESH:D001157
24807533	849	868	neuronal cell death	Disease	MESH:D009410
24807533	912	920	IL-1beta	Gene	3553
24807533	925	934	TNF-alpha	Gene	7124
24807533	961	968	ebselen	Chemical	MESH:C042986
24807533	983	988	death	Disease	MESH:D003643
24807533	1011	1030	neurological damage	Disease	MESH:D020196
24807533	1048	1056	drooping	Disease	
24807533	1134	1142	Ischemic	Disease	MESH:D002545
24807533	1143	1150	gerbils	Species	10045
24807533	1166	1192	impaired glucose tolerance	Disease	MESH:D018149
24807533	1197	1204	insulin	Gene	3630
24807533	1231	1242	post-stroke	Disease	MESH:D020521
24807533	1243	1256	hyperglycemia	Disease	MESH:D006943
24807533	1336	1343	Ebselen	Chemical	MESH:C042986
24807533	1412	1420	IL-1beta	Gene	3553
24807533	1425	1434	TNF-alpha	Gene	7124
24807533	1446	1454	Ischemia	Disease	MESH:D007511
24807533	1479	1486	insulin	Gene	3630
24807533	1516	1521	GLUT2	Gene	6514
24807533	1526	1537	glucokinase	Gene	2645
24807533	1547	1554	ebselen	Chemical	MESH:C042986
24807533	1626	1631	PEPCK	Gene	5106
24807533	1685	1692	ebselen	Chemical	MESH:C042986
24807533	1704	1714	I/R injury	Disease	MESH:D015427
24807533	1791	1798	glucose	Chemical	MESH:D005947
24807533	1829	1837	diabetes	Disease	MESH:D003920
24807533	1842	1861	Alzheimer's disease	Disease	MESH:D000544
24807533	Negative_Correlation	MESH:C042986	5106
24807533	Negative_Correlation	MESH:C042986	MESH:D003920
24807533	Association	MESH:D005947	MESH:D000544
24807533	Negative_Correlation	MESH:C042986	MESH:D020196
24807533	Positive_Correlation	MESH:D001157	3553
24807533	Negative_Correlation	MESH:C042986	MESH:D005947
24807533	Negative_Correlation	MESH:C042986	MESH:D000544
24807533	Negative_Correlation	MESH:C042986	MESH:D003643
24807533	Association	MESH:D002545	3630
24807533	Positive_Correlation	MESH:D001157	7124
24807533	Association	MESH:D005947	MESH:D003920
24807533	Negative_Correlation	MESH:C042986	MESH:D006943
24807533	Negative_Correlation	MESH:D007511	3630
24807533	Association	MESH:D007511	2645
24807533	Negative_Correlation	MESH:C042986	3553
24807533	Positive_Correlation	MESH:C042986	3630
24807533	Association	MESH:D007511	6514
24807533	Negative_Correlation	MESH:C042986	MESH:D009410
24807533	Negative_Correlation	MESH:C042986	7124
24807533	Negative_Correlation	MESH:C042986	MESH:D015427

